About Us

About Us

     PB & T Project is an international, dynamic and innovative pharmaceutical wholesaler, fully licensed by the MHRA since 2011. We operate from two different countries - the United Kingdom and Lithuania. With thousands of products in our portfolio, we provide better access to life-critical medicines worldwide. We specialise in the supply of Branded & Generic Medicines, Medical Devices, Diagnostics, OTC Products and Dermatological Cosmetics to wholesale distributors, pharmacy chains, clinics and government organisations.

     The PB & T Project portfolio is based on our customers’ requirements and therefore our sourcing services are tailored as per clients’ needs.

     PB & T Project is a fast-growing business, successfully serving global healthcare markets for almost ten years. During this time, we have expanded to cover the needs of more than 30 countries in Europe, the Middle East, the CIS and Asia. We are constantly expanding our portfolio, trading all over the world and are always keen to develop new export opportunities.

     It is of the utmost importance to us to ensure products are consistently stored, transported and handled under suitable conditions and that product users are thus safeguarded against potential hazards arising from poor distribution practices. PB & T Project has been GDP certified since 2016, complying with the principles of good distribution practice requirements referred to in Article 84 of Directive 2001/83/E. We also fully comply with all obligations arising from the Falsified Medicines Directive (Directive 2011/62/EU).



    Our strong presence in the Baltic countries and understanding of regional regulatory complexities make us the perfect partner for pharmaceutical companies importing products from Eastern European region.

     In 2016 we founded our subsidiary PB & T Project Ltd Filialas in Lithuania, which is strengthening our position in the Baltics by developing new activities and engagements with potential partners.



PB & T Project has three accredited contracted wholesale activity premises in the UK and Lithuania including third party manufacturing and controlled drugs distribution sites.


With more than 30 different routes, ensuring the quality and the integrity of medicinal products are maintained throughout the distribution chain in the transportation of pharmaceuticals is a vital part of our business. Therefore, we:

All of our outsourced activities covered by the GDP guide are defined in a written contract, controlled and audited on regular basis, ensuring the proper storage, handling and distribution of medicinal products.



These values are part of who we are, what we stand for and how we aspire to do business every day with our business partners and each other.